An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Clinical trial NCT00256113 · COMPLETED

Trial details

NCT number: NCT00256113
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2004-12-01
Primary completion: 2006-12-01
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.